Search Result

Results for "

IIA

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adrenergic Receptor (1) Antibiotic (3) Apoptosis (3) Autophagy (2) Bacterial (3) Biochemical Assay Reagents (1) Carboxylesterase (1) Cholinesterase (ChE) (1) CRAC Channel (2) Drug Intermediate (1) Drug Metabolite (1) EBV (1) Endogenous Metabolite (1) Factor Xa (3) HDAC (8) HSV (1) Integrin (1) Phosphatase (1) Phospholipase (10) PKD (1) SARS-CoV (1) Survivin (2) TGF-beta/Smad (1) Thrombin (4) Topoisomerase (1) VEGFR (3) Wnt (1) β-catenin (6)
By Research Areas:	Cancer (29) Cardiovascular Disease (13) Infection (6) Inflammation/Immunology (12) Metabolic Disease (6) Neurological Disease (6)

By Targets:

Adrenergic Receptor (1)

Antibiotic (3)

Apoptosis (3)

Autophagy (2)

Bacterial (3)

Biochemical Assay Reagents (1)

Carboxylesterase (1)

Cholinesterase (ChE) (1)

CRAC Channel (2)

Drug Intermediate (1)

Drug Metabolite (1)

EBV (1)

Endogenous Metabolite (1)

Factor Xa (3)

HDAC (8)

HSV (1)

Integrin (1)

Phosphatase (1)

Phospholipase (10)

PKD (1)

SARS-CoV (1)

Survivin (2)

TGF-beta/Smad (1)

Thrombin (4)

Topoisomerase (1)

VEGFR (3)

Wnt (1)

β-catenin (6)

By Research Areas:

Cancer (29)

Cardiovascular Disease (13)

Infection (6)

Inflammation/Immunology (12)

Metabolic Disease (6)

Neurological Disease (6)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N1370

*Tanshinone IIA* sulfonate sodium** 5+ Cited Publications Sodium Tanshinone IIA sulfonate; Tanshinone IIA sodium sulfonate	CRAC Channel	Cardiovascular Disease Cancer
Tanshinone IIA sulfonate (sodium) is a derivative of tanshinone IIA, which acts as an inhibitor of store-operated Ca ²⁺ entry (SOCE), and is used to treat cardiovascular disorders.

HY-N0135

Tanshinone IIA 15+ Cited Publications Dan Shen ketone	VEGFR	Cardiovascular Disease Cancer
Tanshinone IIA (Tan IIA) is one of the main compositions in the root of Salvia miltiorrhiza Bunge. Tanshinone IIA may suppress angiogenesis by targeting the protein kinase domains of VEGF/VEGFR2.

HY-N6915

Mogroside II-A	Others	Metabolic Disease Inflammation/Immunology
Mogroside II-A is a natural product isolated from Siraitia grosvenorii .

HY-N7177

Hydroxytanshinone IIA	Drug Metabolite VEGFR	Cancer
Hydroxytanshinone IIA is a hydroxylated metabolite of Tanshinone IIA. Tanshinone IIA may suppress angiogenesis by targeting the protein kinase domains of VEGF/VEGFR2 .

HY-P10053

*sPLA2-IIA* Inhibitor**	Phospholipase	Metabolic Disease
sPLA2-IIA Inhibitor is a cyclic pentapeptide analog of FLSYK (cyclic 2-Nal-Leu-Ser-2-Nal-Arg (c2)), that binds to hGIIA (human IIA phospholipase A2) and inhibits its hydrolytic ability. sPLA2 is a member of the esterase superfamily that catalyzes the hydrolysis of the ester bond at the sn-2 position of glycerophospholipids, releasing free fatty acids such as arachidonic acid and lysophospholipids .

HY-N0135R

*Tanshinone IIA* (Standard)**	VEGFR	Cardiovascular Disease Cancer
Tanshinone IIA (Standard) is the analytical standard of Tanshinone IIA. This product is intended for research and analytical applications. Tanshinone IIA (Tan IIA) is one of the main compositions in the root of Salvia miltiorrhiza Bunge. Tanshinone IIA may suppress angiogenesis by targeting the protein kinase domains of VEGF/VEGFR2.

HY-N1370R

*Tanshinone IIA* sulfonate (sodium) (Standard)**	CRAC Channel	Cardiovascular Disease Cancer
Tanshinone IIA sulfonate (sodium) (Standard) is the analytical standard of Tanshinone IIA sulfonate (sodium). This product is intended for research and analytical applications. Tanshinone IIA sulfonate (sodium) is a derivative of tanshinone IIA, which acts as an inhibitor of store-operated Ca2+ entry (SOCE), and is used to treat cardiovascular disorders.

HY-107248

Escin IIa	Others	Inflammation/Immunology
Escin IIa, isolated from horse chestnut, the seeds of Aesculus hippocastanum L., has positive effects on acute inflammation in animals. Escin IIa has gastroprotections on ethanol-induced gastric mucosal lesions in rats .

HY-N1988R

*Cucurbitacin IIa* (Standard)**	Survivin Apoptosis	Cancer
Cucurbitacin IIa (Standard) is the analytical standard of Cucurbitacin IIa. This product is intended for research and analytical applications. Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells .

HY-169126

*β-catenin modulator IIa-661*	β-catenin Wnt	Cancer
β-catenin modulator IIa-661 is a β-catenin modulator that modulates β-catenin activity and inhibits the activity of the Wnt/wingless (wg) signaling pathway. β-catenin modulator IIa-661 can be utilized in cancer research .

HY-133965

Cinchonain IIa	Others	Inflammation/Immunology
Cinchonain IIa is an antioxidant agent with EC₅₀s of 6.8 μM and 26.5 μM for DPPH and PMS-NADH .

HY-N11696

1-Oxotanshinone IIA	Others	Inflammation/Immunology
1-Oxotanshinone IIA (Compound 6) is extracted from Perovskia artemisioides and has significant anti-inflammatory activity .

HY-N6855

*Mogroside IIA1*	Others	Metabolic Disease Cancer
Mogroside IIA1 is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities .

HY-N7752

3α-Hydroxytanshinone IIA	Others	Others
3α-Hydroxytanshinone IIA (Compound 5) is a compound that can be isolated from the roots of Saluia miltiorrhiza .

HY-N6650

Isotanshinone IIA	Phosphatase	Metabolic Disease
Isotanshinone IIA, an abietane-type diterpene metabolite, could non-competitively inhibit Protein Tyrosine Phosphatase 1B (PTP1B) activity with an IC₅₀ 0f 11.4 μM.

HY-159977

1,2-Didehydrotanshinone IIA	Cholinesterase (ChE)	Others
1,2-Didehydrotanshinone IIA is a moderate AChE and BChE inhibitor, with an IC₅₀ value of 5.98 μM for BChE .

HY-N10686

*Tanshinone IIA* anhydride**	Carboxylesterase	Cancer
Tanshinone IIA anhydride is a potent and irreversible human carboxylesterase (CE) inhibitor with K_i values of 1.9 nM and 1.4 nM for human CE1 and the human intestinal CE (hiCE), respectively .

HY-N7041

11-Oxomogroside IIa	EBV HSV	Infection
11-Oxomogroside IIa (11-oxomogroside II A1) is a cucurbitane glycoside extracted from the fruits of Siraitia grosVenorii. 11-Oxomogroside IIa has inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor .

HY-N1988

Cucurbitacin IIa Hemslecin A	Survivin Apoptosis	Cancer
Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells .

HY-14936

Sofigatran MCC-977	Thrombin	Cardiovascular Disease
Sofigatran (MCC-977) is an orally active *factor IIa* (thrombin)** inhibitor, acts as an anticoagulant. Sofigatran is used for the research of cardiovascular disease .

HY-N6686

Virginiamycin M1 1 Publications Verification Pristinamycin IIA; Ostreogrycin A	Bacterial Antibiotic	Infection
Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665) . Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL.

HY-N12012

11-Oxomogroside II A2 11-Dehydroxy-mogroside IIA2 O-rhamnoside	Others	Others
11-Oxomogroside II A2 (11-Dehydroxy-mogroside IIA2 O-rhamnoside) (compound 101) is a mogroside isolated from the fruit of Luo Han Guo .

HY-N12552

*Cucurbitacin IIa* 2-O-β-D-glucoside** Hemslecin A 2-O-β-d-glucopyranoside	Others	Infection
Cucurbitacin IIa 2-O-β-D-glucoside is a glycoside cucurbitacin isolated from the genus Hemsleya (Cucurbitaceae). Extracts of Hemsleya have the potential to be used in research on bronchitis, bacillary dysentery, and tuberculosis .

HY-NP001

Cationic Bovine Serum Albumin Cationic Bovine Serum Albumin	Biochemical Assay Reagents	Neurological Disease
Cationic Bovine Serum Albumin is a 583 amino acid protein consisting of three homologous full alpha structural domains. Cationic Bovine Serum Albumin has remarkable neuroprotective effects on ischemic stroke when in combination with Tanshinone IIA (HY-N0135) .

HY-118052

BPKDi	PKD	Cardiovascular Disease
BPKDi is a potent bipyridyl PKD inhibitor with IC₅₀s of 1 nM, 9 nM and 1 nM for PKD1, PKD2 and PKD3, respectively. BPKDi blocks signal-dependent phosphorylation and nuclear export of class IIa HDACs in cardiomyocytes .

HY-13402

Varespladib 5 Publications Verification LY315920	Phospholipase	Inflammation/Immunology
Varespladib (LY315920) is a potent and selective *group IIA, secretory phospholipase A₂ (sPLA₂)* inhibitor with an IC₅₀ of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC₅₀s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively .

HY-13402A

Varespladib sodium 5 Publications Verification LY315920 sodium	Phospholipase	Inflammation/Immunology
Varespladib sodium (LY315920 sodium) is a potent and selective *group IIA, secretory phospholipase A₂ (sPLA₂)* inhibitor with an IC₅₀ of 9 nM. Varespladib sodium exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC₅₀s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively .

HY-153678

β-Catenin modulator-1	β-catenin	Cancer
β-Catenin modulator-1 (IIa-650) is a β-Catenin modulator useful in cancer research .

HY-153679

β-Catenin modulator-2	β-catenin	Cancer
β-Catenin modulator-2 (compound IIa-130), an oxazole and thiazole compound, is a potent and selective β-Catenin modulator .

HY-153680

β-Catenin modulator-3	β-catenin	Cancer
β-Catenin modulator-3 (compound IIa-112), an oxazole and thiazole compound, is a potent and selective β-Catenin modulator .

HY-153682

β-Catenin modulator-5	β-catenin	Cancer
β-Catenin modulator-5 (compound IIa-84), an oxazole and thiazole compound, is a potent and selective β-Catenin modulator .

HY-153681

β-Catenin modulator-4	β-catenin	Cancer
β-Catenin modulator-4 (compound IIa-92), an oxazole and thiazole compound, is a potent and selective β-Catenin modulator .

HY-11059

sPLA2 inhibitor 1	Phospholipase	Inflammation/Immunology
sPLA2 inhibitor 1, a D-tyrosine derivative, is an orally active, potent secretory phospholipase A₂ (sPLA₂) inhibitor with an IC₅₀ of 29 nM for human nonpancreatic secretory PLA₂ isoform IIa (hnpsPLA₂-IIa). sPLA2 inhibitor 1 has anti-inflammatory activity .

HY-N7327

Ochnaflavone	Phospholipase	Inflammation/Immunology
Ochnaflavone is an inhibitor of IIA-type secretory phospholipase A2 (sPLA2-IIA) with an IC₅₀ of 3.45 µM. Ochnaflavone exhibits significant anti-inflammatory and liver-protective effects, capable of inhibiting the degradation of phosphatidylethanolamine (PE) and lipid peroxidation induced by carbon tetrachloride (CCl4) in rat liver, with an IC₅₀ of 7.16 µM for lipid peroxidation. Ochnaflavone can be used in research on liver damage and inflammatory diseases .

HY-16914

MC1568 5+ Cited Publications	HDAC	Cancer
MC1568 is a selective class II (IIa) histone deacetylas (HDAC II) inhibitor, used for cancer research.

HY-112605

sPLA2-X Inhibitor 31	Phospholipase	Cardiovascular Disease
sPLA2-X Inhibitor 31 is a selective secreted phospholipase A₂ type X (sPLA₂-X) inhibitor with IC₅₀s of 26 nM, 310 nM, and 2230 nM for sPLA₂-X, *sPLA₂-IIa, and sPLA₂-V*, respectively .

HY-108272

Mogroside II-A2	Others	Metabolic Disease Cancer
Mogroside II-A2 is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities .

HY-W031307

Topoisomerase IIα-IN-8	Topoisomerase	Cancer
Topoisomerase IIα-IN-8 (compound 15) is a weak *human DNA topoisomerase IIa* (htIIa) inhibitor, with an IC₅₀** of 462 ± 38.0 μM .

HY-119939

CHDI-390576	HDAC	Cancer
CHDI-390576, a potent, cell permeable and CNS penetrant *class IIa* histone deacetylase (HDAC) inhibitor with IC₅₀*s of 54 nM, 60 nM, 31 nM, 50 nM for class IIa* HDAC4, HDAC5, HDAC7, HDAC9, respectively, shows >500-fold selectivity over class I HDACs (1, 2, 3) and ~150-fold selectivity over HDAC8 and the class IIb HDAC6 isoform .

HY-N0134

Tanshinone I 3 Publications Verification Tanshinone A	Phospholipase	Cardiovascular Disease Cancer
Tanshinone I is an inhibitor of type IIA human recombinant sPLA₂ (IC₅₀=11 μM) and rabbit recombinant cPLA₂ (IC₅₀=82 μM).

HY-18361

TMP195 10+ Cited Publications	HDAC	Cancer
TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor with K_is of 59, 60, 26, 15 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.

HY-149285

NT160	HDAC	Neurological Disease
NT160 is a highly potent *class-IIa* HDAC inhibitor with an IC₅₀** value of 0.046 μM. NT160 can be used for the research of central nervous system diseases .

HY-120078

AZD2716	Phospholipase
AZD2716 is a selective sPLA₂ (secretory phospholipase A2) inhibitor. AZD2716 significantly reduces the production of pro-inflammatory lipids by inhibiting *sPLA₂-IIa* (IC₅₀ = 10 nM), sPLA₂-V (IC₅₀ = 40 nM), and sPLA₂-X (IC₅₀ = 400 nM), thereby decreasing macrophage activation and foam cell formation. AZD2716 is promising for studying mechanisms related to atherosclerosis and inflammatory diseases associated with sPLA₂ .

HY-18360

TMP269 10+ Cited Publications	HDAC	Cancer
TMP269 is a novel and selective class IIa histone deacetylase (HDAC) inhibitor with IC₅₀s of 157 nM, 97 nM, 43 nM and 23 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.

HY-107393

LY-311727	Phospholipase	Inflammation/Immunology
LY-311727 is a potent secretory non-pancreatic phospholipase A₂ (sPLA₂) inhibitor (IC₅₀ <1 μM for group IIA sPLA₂). sPLA₂ is an important proinflammatory enzyme .

HY-17567A

Heparin sodium salt Maximum Cited Publications 40 Publications Verification Sodium heparin; Sodium heparinate	Thrombin Factor Xa Autophagy	Cardiovascular Disease Cancer
Heparin sodium salt (Sodium heparin) is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa. Heparin sodium salt significantly inhibits exosome-cell interactions.

HY-P990720

Elritercept KER-050	TGF-beta/Smad	Inflammation/Immunology
Elritercept (KER-050) is a recombinant fusion protein comprising a modified activin receptor type IIA extracellular domain fused to a human IgG1 Fc. Elritercept inhibits activin A and other select TGF-β superfamily ligands .

HY-N0134R

Tanshinone I (Standard)	Phospholipase	Cardiovascular Disease Cancer
Tanshinone I (Standard) is the analytical standard of Tanshinone I. This product is intended for research and analytical applications. Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC₅₀=11 μM) and rabbit recombinant cPLA2 (IC₅₀=82 μM).

HY-17567C

Heparin sodium salt (MW 15kDa) 1 Publications Verification Sodium heparin (MW 15kDa); Sodium heparinate (MW 15kDa)	Thrombin Factor Xa Autophagy	Cardiovascular Disease
Heparin sodium salt (MW 15kDa) (Sodium heparin (MW 15kDa)) is a polymer of Heparin with the molecular weight of 15kDa. Heparin sodium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa .

HY-158792

GK241	Others	Others
GK241 (compound 31a-c) is a 2-oxoamide-based compound that has inhibitory activity against human and mouse group IIA secretory phospholipase A2 (GIIA sPLA2) (IC₅₀ of 143 nM and 68 nM, respectively), and its inhibitory mechanism was studied by molecular dynamics simulation.

Cat. No.	Product Name	Type

HY-NP001

Cationic Bovine Serum Albumin Cationic Bovine Serum Albumin	Native Proteins
Cationic Bovine Serum Albumin is a 583 amino acid protein consisting of three homologous full alpha structural domains. Cationic Bovine Serum Albumin has remarkable neuroprotective effects on ischemic stroke when in combination with Tanshinone IIA (HY-N0135) .

Cat. No.	Product Name	Target	Research Area

HY-P10053

*sPLA2-IIA* Inhibitor**	Phospholipase	Metabolic Disease
sPLA2-IIA Inhibitor is a cyclic pentapeptide analog of FLSYK (cyclic 2-Nal-Leu-Ser-2-Nal-Arg (c2)), that binds to hGIIA (human IIA phospholipase A2) and inhibits its hydrolytic ability. sPLA2 is a member of the esterase superfamily that catalyzes the hydrolysis of the ester bond at the sn-2 position of glycerophospholipids, releasing free fatty acids such as arachidonic acid and lysophospholipids .

Cat. No.	Product Name	Target	Research Area

HY-P99333

Volociximab M200; Eos 200-4	Integrin	Cardiovascular Disease Cancer
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC₅₀=0.2 nM). Integrin α5β1 is a major fibronectin receptor involved in angiogenesis. Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs) .

HY-P990720

Elritercept KER-050	TGF-beta/Smad	Inflammation/Immunology
Elritercept (KER-050) is a recombinant fusion protein comprising a modified activin receptor type IIA extracellular domain fused to a human IgG1 Fc. Elritercept inhibits activin A and other select TGF-β superfamily ligands .

Species:	Human (10) Rhesus Macaque (1) Rat (1) Mouse (2) E.coli (2) Cynomolgus (2)
Tag:	His (14) Tag Free (1) Avi (6) Fc (4)
Source:	HEK293 (16) E. coli (2)

Cat. No.	Compare	Product Name	Species	Source

HY-P75537

	ACVR2A/Activin RIIA Protein, Human (HEK293, Fc) ACVR-2A; Activin receptor type 2A; ACTR-IIA; ACVR2	Human	HEK293
	ACVR2A, also known as Activin RIIA, is an activin type II receptor. On ligand binding, ACVR2A can forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. ACVR2A is a receptor for Activin A, Activin B and Inhibin A. ACVR2A/Activin RIIA Protein, Human (HEK293, Fc) is produced in HEK293 cells with a C-Terminal Fc-tag. It consists of 134 amino acids (M1-P134).

HY-P75563

	ACVR2A/Activin RIIA Protein, Mouse (HEK293, His) ACVR-2A; Activin receptor type 2A; ACTR-IIA; ACVR2	Mouse	HEK293
	ACVR2A, also known as Activin RIIA, is an activin type II receptor. On ligand binding, ACVR2A can forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. ACVR2A is a receptor for Activin A, Activin B and Inhibin A. ACVR2A/Activin RIIA Protein, Mouse (HEK293, His) is produced in HEK293 cells with a C-Terminal His-tag. It consists of 134 amino acids (M1-P134).

HY-P70711

	Fc gamma RIIA/CD32a Protein, Human (HEK293, His) Low affinity immunoglobulin gamma Fc region receptor II-a; IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIA; FcRII-a; CD32; FCGR2A; FCG2; FCGR2A1; IGFR2	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (HEK293, His) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-6*His labeled tag and H167, , , , mutation.

HY-P70478

	Fc gamma RIIA/CD32a Protein, Human (183a.a, H167R, HEK293, His) Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a; IgG Fc receptor II-a; CDw32; Fc-Gamma RII-a; Fc-Gamma-RIIA; FcRII-a; CD32; FCGR2A; CD32; FCG2; FCGR2A1; IGFR2	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (H167R, HEK293, His) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-6*His labeled tag and H167R mutation.

HY-P703683

	RIIA/ACVR2A Protein, Rat (HEK293, His) Activin receptor type-2A; Activin receptor type IIA; ACTR-IIA; Acvr2a; ACTR-IIA	Rat	HEK293

HY-P701907

	gyrB Protein, E.coli (Y5S, N198D) gyrB; DNA gyrase subunit B; Type IIA topoisomerase subunit GyrB	E.coli	E. coli
	The GyrB protein negatively supercoils DNA, making it more accessible to topoisomerase 4. gyrB Protein, E.coli is the recombinant E. coli-derived gyrB protein, expressed by E. coli , with tag free. The total length of gyrB Protein, E.coli is 391 a.a., .

HY-P701908

	gyrB Protein, E.coli (Y5S, N198D, His) gyrB; DNA gyrase subunit B; Type IIA topoisomerase subunit GyrB	E.coli	E. coli
	The GyrB protein negatively supercoils DNA, making it more accessible to topoisomerase 4. gyrB Protein, E.coli (Y5S, N198D, His) is the recombinant E. coli-derived gyrB protein, expressed by E. coli , with N-6*His labeled tag. The total length of gyrB Protein, E.coli (His) is 391 a.a., .

HY-P703977

	ACVR2A/Activin RIIA Protein, Human/Cynomolgus (Biotinylated, HEK293, His, Avi) ACTR-IIA; ACTRIIA; ACVR2A; ACVR2	Human	HEK293

HY-P703995

	ACVR2A/Activin RIIA Protein, Human/Cynomolgus (Biotinylated, HEK293, hFc, Avi) ACTR-IIA; ACTRIIA; ACVR2A; ACVR2	Human	HEK293

HY-P75562

	ACVR2A/Activin RIIA Protein, Mouse (HEK293, His-Fc) ACVR-2A; Activin receptor type 2A; ACTR-IIA; ACVR2	Mouse	HEK293
	ACVR2A, also known as Activin RIIA, is an activin type II receptor. On ligand binding, ACVR2A can forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. ACVR2A is a receptor for Activin A, Activin B and Inhibin A. ACVR2A/Activin RIIA Protein, Mouse (HEK293, His-Fc) is produced in HEK293 cells with a C-Terminal His-tag and a C-Terminal Fc-tag. It consists of 134 amino acids (M1-P134).

HY-P75647

	Fc gamma RIIA/CD32a Protein, Rhesus Macaque (HEK293, His) Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a; CD32; FCGR2A; FCG2; IGFR2	Rhesus Macaque	HEK293
	The Fc γ RIIA/CD32a protein plays a key role by specifically binding to the Fc region of immunoglobulin γ, acting as a low-affinity receptor. Fc γ RIIA/CD32a initiates cellular responses against pathogens and soluble antigens and plays an important role in immune regulation. Fc γ RIIA/CD32a interacts with PI3K and Syk. Fc gamma RIIA/CD32a Protein, Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-His labeled tag. The total length of Fc gamma RIIA/CD32a Protein, Rhesus Macaque (HEK293, His) is 184 a.a., with molecular weight of ~25-35 kDa.

HY-P75642

	Fc gamma RIIA/CD32a Protein, Cynomolgus (Biotinylated, HEK293, His-Avi) Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a; CD32; FCGR2A; FCG2; IGFR2	Cynomolgus	HEK293

HY-P75644

	Fc gamma RIIA/CD32a Protein, Human (H167R, HEK293, Fc) Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a; CD32; FCGR2A; FCG2; IGFR2	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (H167R, HEK293, Fc) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-hFc labeled tag and H167R, , , , mutation.

HY-P75645

	Fc gamma RIIA/CD32a Protein, Human (H167R, HEK293, His-Avi) Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a; CD32; FCGR2A; FCG2; IGFR2	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (H167R, HEK293, His-Avi) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-Avi, C-His labeled tag and H167R, , , , mutation.

HY-P78100

	Fc gamma RIIA/CD32a Protein, Human (Biotinylated, HEK293, His-Avi) CD32MGC23887; CDw32fc-gamma-RIIA; Fc gamma RIIA; FCG2; Fc-gamma-RIIA; FcGR; FCGR2; FCGR2A; FCGR2A1; FcgRIIA; FCRIIA; fcRII-a; IGFR2MGC30032; IgG Fc receptor II-a; FCG2; CD32A	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-Avi, C-His labeled tag and H167 mutation.

HY-P78265

	Fc gamma RIIA/CD32a Protein, Cynomolgus (HEK293, His) CD32MGC23887; CDw32fc-gamma-RIIA; Fc gamma RIIA; FCG2; Fc-gamma-RIIA; FcGR; FCGR2; FCGR2A; FCGR2A1; FcgRIIA; FCRIIA; fcRII-a; IGFR2MGC30032; IgG Fc receptor II-a; FCG2; CD32A	Cynomolgus	HEK293

HY-P78423

	Fc gamma RIIA/CD32a Protein, Human (HEK293, His-Avi) CD32MGC23887; CDw32fc-gamma-RIIA; Fc gamma RIIA; FCG2; Fc-gamma-RIIA; FcGR; FCGR2; FCGR2A; FCGR2A1; FcgRIIA; FCRIIA; fcRII-a; IGFR2MGC30032; IgG Fc receptor II-a; FCG2; CD32A	Human	HEK293
	Fc gamma The RIIA/CD32a protein plays a key role as a low-affinity receptor that specifically binds to the Fc region of immunoglobulin gamma. It interacts with IgG to initiate cellular responses against pathogens, which is critical for immune regulation. Fc gamma RIIA/CD32a Protein, Human (HEK293, His-Avi) is the recombinant human-derived Fc gamma RIIA/CD32a protein, expressed by HEK293 , with C-Avi, C-His labeled tag and H167 mutation.

HY-P700752

	Integrin alpha 2 beta 1 Protein, Human (HEK293, His) α2β1; Integrin alpha A1 beta 1; alpha A1 beta 1; alpha A1; beta 1; ITGA1&ITGB1; ITGA&ITGB; VLA-2, GPIa-IIA, CD49b; Integrin alpha A1 β 1; alpha A1 β 1; β 1	Human	HEK293
	ITGA2 Protein, a transmembrane receptor, is involved in cell adhesion, platelet aggregation, and tumor metastasis. Dysregulation of ITGA2 Protein has been associated with various disorders, including thrombosis and cancer. Targeting ITGA2 Protein may offer potential therapeutic interventions in these conditions by modulating cell adhesion, inhibiting blood clot formation, and preventing tumor metastasis. Integrin alpha 2 beta 1 Protein, Human (HEK293, His) is a recombinant protein dimer complex containing human-derived Integrin alpha 2 beta 1 protein, expressed by HEK293, with C-His labeled tag. Integrin alpha 2 beta 1 Protein, Human (HEK293, His), has molecular weight of 110-140 kDa.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P83050

	*Activin Receptor Type IIA* Antibody (YA2795)** ACTR2; ACTRII; ACTRIIA; Acvr2; ACVR2A	WB	Human, Mouse, Rat
	Activin Receptor Type IIA Antibody (YA2795) is a biotin-conjugated non-conjugated IgG antibody, targeting Activin Receptor Type IIA, with a predicted molecular weight of 58 kDa (observed band size: 85 kDa). Activin Receptor Type IIA Antibody (YA2795) can be used for WB experiment in human, mouse, rat background.

HY-P83368

	MYH9 Antibody (YA3113) MHA; FTNS; EPSTS; BDPLT6; DFNA17; MATINS; NMMHCA; NMHC-II-A; NMMHC-IIA	WB, IHC-P, IP	Human, Rat
	MYH9 Antibody (YA3113) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3113), targeting MYH9, with a predicted molecular weight of 227 kDa (observed band size: 227 kDa). MYH9 Antibody (YA3113) can be used for WB, IHC-P, IP experiment in human, rat background.

HY-P80445

	CaMKII alpha Antibody 1 Publications Verification Alpha CaMKII; Calcium calmodulin dependent protein kinase II; Calcium/calmodulin dependent protein kinase II alpha B subunit; Calcium/calmodulin dependent protein kinase type II alpha chain; Calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha; Calcium/calmodulin-dependent protein kinase II alpha; Calcium/calmodulin-dependent protein kinase II-alpha; Calcium/calmodulin-dependent protein kinase type II subunit alpha; Calcium/calmodulin-dependent protein kinase type IIA; CaM kinase II alpha chain; CaM kinase II alpha subunit; CaM kinase II subunit alpha; CaMK II alpha subunit; CaMK-II subunit alpha; Camk2a; CAMKA; CaMKII; CaMKIINalpha; EC2.7.11.17; KCC2A_HUMAN; KIAA0968; MGC123320; MGC139375; MGC155201; mKIAA0968; PK2CDD; PKCCD; R74975; zgc:112538; zgc:123320;	WB, IP, FC, IHC-P	Human, Mouse, Rat
	CaMKII alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to CaMKII alpha. It can be used for WB,IP,FC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

HY-P82716

	Protein C Antibody (YA2461) PROC; Vitamin K-dependent protein C; Anticoagulant protein C; Autoprothrombin IIA; Blood coagulation factor XIV	WB	Human
	Protein C Antibody (YA2461) is a biotin-conjugated non-conjugated IgG antibody, targeting Protein C, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Protein C Antibody (YA2461) can be used for WB experiment in human background.

HY-P83505

	CD32 Antibody (YA3250) FCGR2A; CD32; FCG2; FCGR2A1; IGFR2; Low affinity immunoglobulin gamma Fc region receptor II-a; IgG Fc receptor II-a; CDw32; Fc-gamma RII-a; Fc-gamma-RIIA; FcRII-a; CD32	WB, IHC-P	Human
	CD32 Antibody (YA3250) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3250), targeting CD32, with a predicted molecular weight of 35 kDa (observed band size: 43 kDa). CD32 Antibody (YA3250) can be used for WB, IHC-P experiment in human background.

HY-P82153

	Synapsin 2 Antibody (YA1898) SYN 2; SYN II; SYN IIA; SYN IIb; SYN2; Synapsin2; SynapsinII; SYNII; SYNIIA; SYNIIb	WB, IHC-P	Human, Mouse, Rat
	Synapsin 2 Antibody (YA1898) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1898), targeting Synapsin 2, with a predicted molecular weight of 63 kDa (observed band size: 75 kDa). Synapsin 2 Antibody (YA1898) can be used for WB, IHC-P experiment in human, mouse, rat background.

HY-P83712M

	Rat Anti-Mouse CD16/32 Antibody (FITC) CD16a/b; CD32; CD32A/B; Fc fragment of IgG low affinity IIA/b receptor; Fc fragment of IgG low affinity IIIA/b receptor; Fc fragment of IgG low affinity IIIb receptor; Fc gamma receptor III A/B; FCG2A; FcGR; FCGR2A/BFCGR3; FCGR3A/B; Fc gamma RIIA/b	FC	Mouse